Tapping into the depth and breadth of electronic health record data enables our researchers to develop accurate and scalable computable phenotypes to expand the Heart Disease in Communities cohort and study important risk factors and outcomes in cardiovascular disease.
The Cardiovascular Disease and Outcomes Research Program is a group of physicians and scientists working together to conduct patient-centered research that drives improvements in prevention, diagnosis and treatment.
Our program investigates the individual differences in cardiovascular disease that can ultimately be used to tailor care to a patient's specific molecular and risk profile. Our research also informs models of patient-centered care and can be used to design more-effective interventions to manage patients with cardiovascular disease.
The program, based at Mayo Clinic in Rochester, Minnesota, brings together multidisciplinary teams with expertise in cardiovascular epidemiology, genetic and molecular epidemiology, statistics, data science, and outcomes research.
Much of the work in our program originates from a massive amount of patient data collected through the Heart Disease in Communities cohort. Our researchers mine comprehensive electronic health records from the study that are indexed by the Rochester Epidemiology Project, enabling us to develop accurate and scalable computable phenotypes.
The Cardiovascular Disease and Outcomes Research Program fosters critical interactions among researchers. The program nurtures scientifically promising collaborations, mentorships, grant proposals and projects. The program also supports mentoring and training of junior investigators, didactic training in cardiovascular and molecular epidemiology, and coordination of external collaborations in the field.
Co-directors of the Cardiovascular Disease and Outcomes Research Program are Alanna M. Chamberlain, Ph.D., and Suzette J. Bielinski, Ph.D., M.Ed.
Dr. Chamberlain is an epidemiologist at Mayo Clinic in Rochester and an associate professor of epidemiology at Mayo Clinic College of Medicine and Science. Dr. Bielinski is a genetic epidemiologist at Mayo Clinic in Rochester and a professor of epidemiology at Mayo Clinic College of Medicine and Science.